Expression of heat shock protein 70 and c-myc in cervical carcinoma

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1533-1536

  Abd El All, Howayda ^a   Rey, Annie ^b   Duvillard, Pierre ^b  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

c myc; Cervical carcinoma; hsp70

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 70; MONOCLONAL ANTIBODY; MYC PROTEIN;

ADENOCARCINOMA; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; EPITHELIUM; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASM INVASIVENESS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 0031826984     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the world wide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594-606, 1993.
2. Mokhtar N: Cancer Pathology Registry 1985-1989. ed Department of Pathology NCI 1991.
3. Abd El All H, Awaad HK, EL Ayat A and Nada GM: Natural Killer cells in human cervical carcinoma: immunohistochemical study with the CD57 monoclonal antibody. Master Degree Thesis, Suez Canal University, Ismailiya, Egypt, 1987.
4. Abd El All H, Prade M, Khatab T, Awaad K, Farid A: Immunological study of natural killer cells in cervical carcinoma. PhD Thesis, Suez Canal University, Ismailiya, Egypt 1992.
5. Pelham HRB: Hsp70 accelerates the recovery of nucleolar morphology after heat shock. EMBO 3: 3095-3100, 1984.
6. Milarski KL and Morimoto RI: Expression of human hsp70 during the synthetic phase of the cell cycle. Proc Natl Acad Sci USA 83: 9517-9521, 1986.
7. Koskinen PJ, Sistonen L, Evan G, Morimoto R, Alitalo K: Nuclear colocalisation of cellular and viral myc proteins with HSP70 in mycoverexpressing cells. J Virol 65: 842-851, 1991.
8. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RW, Ullrich S, Romano JW, Apella E, Testa JR, Gerwin BI and Harris CC: p53 mutations, ras mutations, and p53-heat shock protein complexes in human lung carcinoma cell lines. Cancer Res 51: 4090-4096, 1991.
9. Graig EA, Weissman JS and Horwich AL: Heat shock proteins and molecular chaperones: moderators of protein conformation and turnover in the cell. Cell 78: 365-372, 1994.
10. Ciocca DR, Clark MC, Tandon AK, Fuqua SAW, Welch WJ and McGuire WL: Heat-shock protein 70 in patients with axillary lymph-node negative breast cancer: prognostic implications. JNCI 85: 570-573, 1993.
11. Volm M, Koomagi R. Kaufmann M. Mattern J. Stammler G: Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas. Clin Exp Metastasis 14: 209-14, 1996.
12. Thompson CB, Challoner PB, Neiman PE and Groudine M: Levels of c-myc oncogene mRNA are invariant throught the cell-cycle. Nature 413: 363-366, 1985.
13. Muller R, Slamon DJ, Tremblay J, Cline M and Verha IM: Differentiatial expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature 299: 640-644, 1982.
14. Pfeifer-Ohlsson S, Gronsten A and Rydnert J: Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implication for embryonic cell proliferation. Cell 38: 585-595, 1984.
15. Tauchi K, Hori S, Itoh H, Osamura YR, Tokuda Y: Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions with special reference to their prognostic significance in carcinoma. Virkows Archiv A Pathol Anat 416: 65-73, 1989.
16. Pavelic ZP, Steele P and Preisler HD: Evaluation of c-myc oncogene in primary human breast carcinomas. AntiCancer Res 11: 1421-1428, 1991.
17. Kreipe H, Feist H, Fisher L, Felgner J, Heidorn K, Mettler L and Parwaresch R: Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer. Cancer Res 53: 1956-1961, 1993.
18. Spandidos DA, Zakinthinos CP, Petraki C, Sotsiou F, Yiagnisis M, Dimopoulos AM, Roussous C, Field KJ: Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung. Anticancer Res 10: 1105-1114, 1990.
19. Volm M, Efferth T and Mattern J: Oncoprotein (c-myc, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinoma of the lung. Clinical and biological correlations. Anticancer Res 12: 11-20, 1992.
20. Jukawa M, Fujimori T, Hirayama D, Idei Y, Ajiki T, Kawai K, Sugiura R, Maeda and Nagasako K: Expression of oncogene products and growth factors in early gall bladder cancer, advanced gall bladder cancer and chronic cholecystitis. Hum Pathol 24: 37-40, 1993.
21. Porter MJ, Field JK, Leung SF, Lo D, Lee JC, Spandidos DA and van Hasselt CA: The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 114: 105-109, 1994.
22. Riou GF, Lê MG, Le Doussal V, Barrois M, George M and Haie M. C-myc proto-oncogene expression and prognosis in early invasive carcinomas of the uterine cervix. Lancet 2: 761-763, 1987.
23. Riou GF, Bourrhis J and Le MG. The c-myc protooncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer. Anticancer Res 10: 1225-1232, 1990.
24. Iwasaka T, Yokoyama M, Oh-Uchida M, Matsuo N, Hara K, Fukuyama K, Hachisuga T, Fukuda K, Sugimori H: Detection of human papillomas genome and analysis of expression of c-myc and Ha-ras in invasive cervical carcinomas. Gynecol Oncol 46: 298-303, 1992.
25. Devictor B, Bonnier P, Piana L, Andrac L, Lavaut M-N, Allasia C and Charpin C: c-myc protein and KI-67 antigen immunodetection in patients with uterine cervix neoplasia: correlation of microcytophotometric analysis and histologic data. Gynecol Oncol 49: 284-290, 1993.
26. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffmembbeded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
27. Taylor CR, Shi SR, Chaiwun B, Young L, Imam SA, Cote RJ: Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen vetriveal techniques. Hum Pathol 25: 263-270, 1994.
28. Wynford-Thomas D: Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour. J Pathol 165: 187-201, 1991.
29. Yano M, Naito Z, Tanaka S and Asano G: Expression and roles of heat shock proteins in human breast cancer. Jpn J Cancer Res 87: 908-15, 1996.
30. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL and Fuqua SAW: Biological and clinical implications of heat shock protein 27000 (Hsp27): a review. JNCI 85: 1558-1570, 1993.
31. Karayiannis M, Yiagnisis M, Papadimitriou K, Field JK, Spandidos: Evaluation of the ras and myc oncoproteins in begnin gastic lesions. Anticancer Res 10: 1127-1134, 1990.
32. Koskinen PJ and Alitalo K: Role of myc amplification and overexpression in cell growth, differentiation and death. Semin Cancer Biol 4: 3-12, 1993.
33. Gaforio JJ, Pérez M, Algarra I, Mialdea MJ, Ljunggren H and Garrido F: Differential mRNA levels of cmyc, c fos and MHC class I in several clones of a murine fibrosarcoma. Int J Cancer 49: 906-910, 1991.
34. Glew SS and Stern PL: HLA antigens and cervical carcinoma. Nature 356: 22, 1992.
35. Garrido F, Gabrera T, Concha, Glew S, Ruiz-Cabello F and Stern PL: Natural history of HLA expression during tumour development. Immunol Today 14: 491-498, 1993.
36. Parham P: A profitable lesson in hersey. Nature 340: 426-427, 1989.
37. Kauffman SHE. Heat shock proteins and the immune response. Immunol today 11: 129-136, 1990
38. Liu FF, Miller N, Levin W, Zanke B, Cooper B, Henry M, Sherar MD, Pintilie M, Hunt JW and Hill RP: The potential role of HSP70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer. Inter J Hyperthermia 12: 197-10, 1996.